WinfredFunding Intelligence

Back to Investors

CF

Cystic Fibrosis Foundation

Other

Portfolio

1

companies

Portfolio companies

Owlstone Medical

Owlstone Medical provides breath biopsy technology for early disease detection and precision medicine.

Recent investments

Growth25 March 2025

£1.7M

Owlstone Medical secures £1.7m from Cystic Fibrosis Foundation to develop a breath test for cystic fibrosis

The funding will support proof-of-principle work for detecting Pseudomonas aeruginosa infections in patients.

Owlstone Medical—Cambridge, UK

Cystic Fibrosis Foundation